1-3 of 3
Karin Przyklenk, PhD
Close
Sort by
Journal Articles

GLS-409, a Synergistic Inhibitor of Both P2Y 1 and P2Y 12 : Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition

Elena Smolensky Koganov, PhD, Alan D Michelson, MD, Ivan B Yanachkov, PhD, Milka I Yanachkova, PhD, George E Wright, PhD, Karin Przyklenk, PhD, Andrew L Frelinger, III, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 630.
https://doi.org/10.1182/blood.V130.Suppl_1.630.630
Published: 2017
Journal Articles

Detection and Mechanisms of GPIIb-IIIa Antagonist Induced Thrombocytopenia: Role for Antibody Induced Platelet Activation.

Matthew D. Linden, PhD, Andrew L. Frelinger, PhD, Mark I. Furman, MD, Lori A. Krueger, MLT ART, Youfu Li, MD, Marsha L. Fox, MS, RN, Annette Hughes, John Lown, MD, Marc R. Barnard, MS, Karin Przyklenk, PhD, Alan D. Michelson, MD
Journal: Blood
Blood (2005) 106 (11): 1654.
https://doi.org/10.1182/blood.V106.11.1654.1654
Published: 2005
Journal Articles

Patients with Coronary Artery Disease Have an Increased Incidence of Aspirin Resistance: Association of PFA-100 Closure Time with Clinical Findings.

Andrew L. Frelinger, PhD, Matthew D. Linden, PhD, Mark I. Furman, MD, Marsha L. Fox, RN, Marc R. Barnard, MS, Youfu Li, MD, Kurt Barringhaus, MD, Karin Przyklenk, PhD, Alan D. Michelson, MD
Journal: Blood
Blood (2004) 104 (11): 1859.
https://doi.org/10.1182/blood.V104.11.1859.1859
Published: 2004